CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 224 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,950 | +22.4% | 402 | 0.0% | 0.00% | – |
| Q2 2023 | $8,944 | +2.8% | 402 | 0.0% | 0.00% | – |
| Q1 2023 | $8,703 | +6.7% | 402 | 0.0% | 0.00% | – |
| Q4 2022 | $8,160 | -18.4% | 402 | 0.0% | 0.00% | – |
| Q3 2022 | $10,000 | 0.0% | 402 | 0.0% | 0.00% | – |
| Q2 2022 | $10,000 | +11.1% | 402 | 0.0% | 0.00% | – |
| Q1 2022 | $9,000 | +12.5% | 402 | 0.0% | 0.00% | – |
| Q4 2021 | $8,000 | 0.0% | 402 | 0.0% | 0.00% | – |
| Q3 2021 | $8,000 | -11.1% | 402 | 0.0% | 0.00% | – |
| Q2 2021 | $9,000 | -10.0% | 402 | 0.0% | 0.00% | – |
| Q1 2021 | $10,000 | -9.1% | 402 | 0.0% | 0.00% | – |
| Q4 2020 | $11,000 | +57.1% | 402 | 0.0% | 0.00% | – |
| Q3 2020 | $7,000 | 0.0% | 402 | 0.0% | 0.00% | – |
| Q2 2020 | $7,000 | +40.0% | 402 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | 0.0% | 402 | 0.0% | 0.00% | – |
| Q4 2019 | $5,000 | -16.7% | 402 | 0.0% | 0.00% | – |
| Q3 2019 | $6,000 | – | 402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,951,077 | $178,226,000 | 9.95% |
| Parallel Advisors, LLC | 3,769,455 | $96,649,000 | 4.45% |
| Novo Holdings A/S | 3,327,768 | $85,324,000 | 4.07% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $911,000 | 2.72% |
| Quantedge Capital Pte Ltd | 243,712 | $6,249,000 | 1.93% |
| S&T BANK/PA | 349,456 | $8,960,000 | 1.73% |
| Birchview Capital, LP | 50,000 | $1,282,000 | 0.90% |
| Bridge City Capital, LLC | 61,254 | $1,571,000 | 0.86% |
| FAS Wealth Partners, Inc. | 299,576 | $7,681,000 | 0.85% |
| AJ WEALTH STRATEGIES, LLC | 509,934 | $13,075,000 | 0.76% |